Try our Advanced Search for more refined results

South Korea Fines Novartis $48M Over Bribes To Doctors

By Dani Kass (April 27, 2017, 3:06 PM EDT) -- South Korea's Ministry of Health and Welfare has fined Novartis 55 billion South Korean won ($48 million) and stopped reimbursements for the Alzheimer's drug Exelon and chemotherapy drug Zometa after six of the company's executives were charged with bribing doctors to use their products, the drugmaker confirmed Thursday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!